Prohost Biotech - Exclusive Biotech Research - A Comprehensive Resource for Biotech News

Denali Therapeutics: Positive Clinical Results and Regulatory Progress for Development Programs in ALS. See Also: NTLA Tumbling Today

October 8, 2021 0

Denali Therapeutics News Denali Therapeutics (DNLI) - a biopharmaceutical company developing a broad portfolio of product …

Intellia Therapeutics: Authorized to Initiate Phase 1/2 Clinical Trial of NTLA-2002 for Hereditary Angioedema

October 6, 2021 0

Intellia Therapeutics Authorization of CTA for Phase 1/2 Study of NTLA-2002 Intellia Therapeutics (NTLA) announced the …

Atea Pharmaceuticals and Xenon Pharmaceuticals: Two Clinical-Stage Firms That Rallied Instead of Crashing Yesterday

October 5, 2021 0

Two Clinical-Stage Firms Rallied Yesterday On a day when the Stock Market was crushed, taking down …

Merck and Ridgeback Biotherapeutics Announced Successful Phase 3 Trial Results of Molnupiravir for Mild or Moderate COVID-19

October 1, 2021 0

Merck and Ridgeback Biotherapeutics COVID-19 News Merck (MRK) and Ridgeback Biotherapeutics today announced that molnupiravir (MK-4482, EIDD-2801) …

Valneva SE and Pfizer Inc Announce Further Positive Results in Preventing Lyme Disease

September 30, 2021 0

Valneva SE and Pfizer Inc Announced More Positive Trial Results of VLA15 for Lyme Disease What …

Reata Pharmaceuticals Plans to Submit Omaveloxolone NDA for Friedreich’s Ataxia in Q1 2022

September 30, 2021 0

Reata Pharmaceuticals to Submit Omaveloxolone for NDA in Early 2022 In a press release following the …

AstraZeneca Saphnelo Approved in Japan for Adult Patients with SLE

September 28, 2021 0

AstraZeneca Saphnelo Approved by Japanese Ministry of Health, Labor and Welfare Developed by AstraZeneca (AZN), Saphnelo …

The Time Has Come to Present Mirum Pharmaceuticals Inc

September 27, 2021 0

Mirum Pharmaceuticals Inc Mirum Pharmaceuticals Inc (MIRM) is a clinical-stage biopharmaceutical company focused on the development …

The World Health Organization Recommends Regeneron Pharmaceuticals Antibody Cocktail for COVID-19

September 24, 2021 0

Regeneron Welcomes the World Health Organization's Recommendation for Use of REGEN- COVTM to Treat COVID-19 The …

Can Excision BioTherapeutics Inc Cure HIV?!

September 24, 2021 0

Excision BioTherapeutics, Inc. IND Application for EBT-101 for HIV Accepted by the US FDA Excision BioTherapeutics, …

Encouraging News from Cassava Sciences

September 22, 2021 0

Cassava Sciences Announces Top-Line Clinical Data for Simulfilam Cassava Sciences Press Release Today Cassava Sciences (SAVA) …

Seagen Inc and Genmab Announce FDA Accelerated Approval for TIVDAK™ for Cervical Cancer

September 21, 2021 0

Seagen and Genmab Granted FDA Accelerated Approval for TIVDAK™ The U.S. FDA granted accelerated approval to …

Comprehensive Prohost Letter Issues

September 19, 2021 0

The Comprehensive Prohost Letter Issues The Comprehensive Prohost Letter Issues will constitute a chain of 7 …

Gilead Sciences: New Data Demonstrate Trodelvy Survival Benefit in Metastatic TNBC. See Also: Galapagos NV News

September 17, 2021 0

Gilead Sciences New Data from Trodelvy® Study Gilead Sciences (GILD) has recently announced new data from …

The U.S. FDA Accepted Intellia Therapeutics IND Application of NTLA-5001 for Acute Myeloid Leukemia

September 16, 2021 0

Intellia Therapeutics IND Application of NTLA-5001 for AML is Accepted by the US FDA NTLA-5001 is …

Why Jounce Therapeutics Stock is Outperforming Today

September 14, 2021 0

Jounce Therapeutics Jounce Therapeutics (JNCE) is a clinical-stage immunotherapy company developing therapies enabling the immune system …

Regenxbio and AbbVie: A Good Reason for RGNX to Soar Today

September 13, 2021 0

Regenxbio and AbbVie in the NEWS Regenxbio (RGNX) stock soared today. The Company, along with AbbVie …

Why IVERIC bio Stock Rallied Today

September 10, 2021 0

IVERIC bio Stock Rally IVERIC bio (ISEE) stock rallied in early, premarket trading today as Stifel …

Gain Therapeutics: A Biotech with Promising Treatments for Neurodegenerative Diseases and a Note from Prohost Biotech

September 8, 2021 0

Gain Therapeutics Inc in the News Gain Therapeutics, Inc. (GANX) announced today topline data from its …

Interesting, Good News for Impel NeuroPharma and Migraine Sufferers

September 3, 2021 0

Impel NeuroPharma FDA Approval for TRUDHESA The U.S. Food and Drug Administration (FDA) approved Impel NeuroPharma …

Exclusive Market Insight

& Scientific analysis

Latest Articlesddd

Denali Therapeutics: Positive Clinical Results and Regulatory Progress for Development Programs in ALS. See Also: NTLA Tumbling Today

Intellia Therapeutics: Authorized to Initiate Phase 1/2 Clinical Trial of NTLA-2002 for Hereditary Angioedema

Atea Pharmaceuticals and Xenon Pharmaceuticals: Two Clinical-Stage Firms That Rallied Instead of Crashing Yesterday

Merck and Ridgeback Biotherapeutics Announced Successful Phase 3 Trial Results of Molnupiravir for Mild or Moderate COVID-19

Valneva SE and Pfizer Inc Announce Further Positive Results in Preventing Lyme Disease

Reata Pharmaceuticals Plans to Submit Omaveloxolone NDA for Friedreich’s Ataxia in Q1 2022

AstraZeneca Saphnelo Approved in Japan for Adult Patients with SLE

The Time Has Come to Present Mirum Pharmaceuticals Inc

The World Health Organization Recommends Regeneron Pharmaceuticals Antibody Cocktail for COVID-19

Can Excision BioTherapeutics Inc Cure HIV?!

Encouraging News from Cassava Sciences

Seagen Inc and Genmab Announce FDA Accelerated Approval for TIVDAK™ for Cervical Cancer

Comprehensive Prohost Letter Issues

Gilead Sciences: New Data Demonstrate Trodelvy Survival Benefit in Metastatic TNBC. See Also: Galapagos NV News

The U.S. FDA Accepted Intellia Therapeutics IND Application of NTLA-5001 for Acute Myeloid Leukemia

Why Jounce Therapeutics Stock is Outperforming Today

Regenxbio and AbbVie: A Good Reason for RGNX to Soar Today

Why IVERIC bio Stock Rallied Today

Gain Therapeutics: A Biotech with Promising Treatments for Neurodegenerative Diseases and a Note from Prohost Biotech

Interesting, Good News for Impel NeuroPharma and Migraine Sufferers